Medical college | Page 2 of 23

Dr. RK Manchanda – Director General of Central Council of Research in Homoeopathy

Dr. R.K. Manchanda, has joined as Director General of Central Council of Research in Homoeopathy (CCRH India) on 3rd July 2012. A dynamic person, an able administrator, a researcher, an … continue reading

Modern Masters – 8 teachers 5 webinars

The American Medical College of Homeopathy – AMCH has sponsored a 5-Session Course featuring sessions with some of today’s most respected homeopaths from around the world. This 10-hour course will be presented in a series of 5 live webinar sessions.

Understanding the Noble Gases

The Noble gases (Helium, Neon, Argon, Krypton, Xenon and Radon) are some of the least prescribed homeopathic medicines in the materia medica. Jeremy Sherr has been researching and writing about the Noble Gases since 1993, when he first published his proving of Neon. He will be publishing his first book in a series on these remedies, Helium, in 2012.

Exhibition cum seminar on Homoeopathy & Hahnemann

An exhibition cum seminar on Homoeopathy & Hahnemann is organised at Nehru Homoeopathic Medical College (NHMC), Defence Colony, by Institute for the History of Medicine (IGM), of Robert Bosch Foundation, Stuttgart, Germany in collaboration with the Dte of ISM& Homoeopathy.

Honble Minister of Health, Prof. Kiran Walia has consented to be the Chief Guest and inaugurate the exhibition cum seminar on Homoeopathy & Hahnemann at Nehru Homoeopathic Medical College (NHMC), Defence Colony, which is being organised by Institute for the History of Medicine (IGM), of Robert Bosch Foundation, Stuttgart, Germany in collaboration with the Dte of ISM& Homoeopathy on 10th April at 10.00 am.

Eyes :: Surgical errors rare but serious in ophthalmic procedures

Surgical confusions—for instance, operations involving the wrong site, the wrong patient or the wrong procedure—occur infrequently in eye surgery procedures, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Although most surgical confusions cause little or no permanent injury, they may involve serious consequences for the patient, physician and profession, yet could often be prevented.

Multiple Sclerosis :: Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease

An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.

Stem Cell :: Jefferson researchers find stem cells in degenerating spinal discs, potential for repair

Orthopedic researchers at Jefferson Medical College have for the first time found stem cells in the intervertebral discs of the human spine, suggesting that such cells might someday be used to help repair degenerating discs and remedy lower back and neck pain.

COPD :: COPD rates, higher than expected in China, will continue to grow

In China, chronic obstructive pulmonary disease (COPD) in people over the age of 40 is much more prevalent than previously thought, according to researchers in Guangdong.

Heart Disease :: Taking the stress out of choosing the right stress test

Stress tests are good front-line tests indicators of heart disease, but just how good depends on ordering the right one, researchers say. Thirty percent of all women, for example, have a false positive exercise treadmill test, in which they walk for several minutes at a slightly increasing incline with an electrocardiogram measuring the electrical activity of the heart, they say.

Pancreatic Cancer :: Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer

A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 — which normally applies the brakes on a cancer-causing gene — is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.